NOVELIX PHARMACEUTICALS LIMITED

Healthcare · Healthcare Services

BSE: 536565 BSE: 590093
₹70.00
Sept. 30, 2026 · BSE · bse_bhavcopy

Peers in Healthcare Services

The largest companies in the same industry by market cap. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Apollo Hospitals Enterprise Limited 117,407 74.7 20.1% 9.7% — 73 0 27
Max Healthcare Institute Limited 90,492 126.0 13.4% -16.5% 0.22% 77 0 26
Fortis Healthcare Limited 58,132 257.5 10.5% -22.2% 0.13% 49 26 6
Global Health Limited 36,701 76.2 13.9% 4.6% 0.04% 74 0 30
Narayana Hrudayalaya Ltd. 36,609 64.4 17.8% 3.5% 0.25% 66 0 29
Aster DM Quality Care Limited 36,121 207.5 8.8% 10.5% 0.43% 53 0 26
Dr. Lal Path Labs Ltd. 33,310 38.7 20.1% -37.3% 0.98% 82 0 88
Krishna Institute of Medical Sciences Limited 31,349 111.2 9.5% 8.5% — 47 0 29

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value
₹169 Cr
EV / EBITDA
36.5x
EV / Sales
1.15x
Market cap / Sales
1.14x
Earnings yield
2.67%

Quarterly Financials

↑ Positive
Quarterly Revenue

Jun 2026 quarterly revenue is Rs 37 Cr, up 65.2% YoY.

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 37 1 — ₹0.4900
March 31, 2026 25 1 1 ₹0.4300
Dec. 31, 2025 48 1 1 ₹0.5800
Sept. 30, 2025 36 1 1 ₹0.3700
June 30, 2025 22 0 0 ₹0.0900
March 31, 2025 21 0 0 ₹0.1800
Dec. 31, 2024 5 0 0 ₹0.1500
Sept. 30, 2024 4 0 0 ₹0.1600
Dec. 31, 2023 0 -0 -0 ₹-0.0400
Sept. 30, 2023 1 -0 -0 ₹-0.0800
June 30, 2023 2 -0 -0 ₹
March 31, 2023 1 0 0 ₹
Dec. 31, 2022 0 0 0 ₹0.0800

Quarterly income statement (standalone, ₹ Cr)

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Dec 23Sep 23Jun 23Mar 23Dec 22
Total income (before exceptional items)37——36——5411211
Operating revenue3725483622215401210
Other income0——0——0-000000
Operating expenses362447362221——1————
Operating profit111100——-0————
Operating profit margin3.5%5.1%2.7%1.9%0.8%1.1%——-13.7%————
Depreciation0000000000000
Interest000000——0————
Exceptional items, gain / (loss)—————————————
Profit before tax11110000-0-0-000
Tax-000000-00-0—0—-0
Net profit—1110000-0-0-000
EPS0.490.430.580.370.090.180.150.16-0.04-0.08——0.08
Net profit (TTM)—321100-0-0-0-0-0-0
EPS (TTM)1.871.471.220.790.580.450.19—————-0.11

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 23Mar 21Mar 20Mar 18Mar 17
Total income (before exceptional items) — — —2†1†2†3†4†
Operating revenue 355.0% 166.2% 132†1†1†1†3†4†
Other income — — —1†0†0†0†0†
Operating expenses — — 129†—————
Operating profit — — 3†—————
Operating profit margin — — 2.6%†—————
Depreciation — — 0†0†0†0†0†0†
Interest — — 0†—————
Exceptional items, gain / (loss) — — 0†0†0†0†-0†0†
Profit before tax — — 3†-0†-3†0†0†0†
Tax — — 1†———0†—
Net profit — — 3†-0†-3†0†0†0†
EPS — — 1.47†—-4.04†0.11†——

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 23Mar 21Mar 20Mar 18Mar 17
Operating margin2.6%†—————
EBIT margin2.6%†—————
PBT margin2.6%†-4.1%†-330.7%†9.2%†9.7%†5.8%†
Net margin1.9%†-4.6%†-330.4%†8.1%†6.2%†4.3%†
Interest coverage——————
Dividend payout——————
Earnings retention——————
Current ratio2.14x—————
Quick ratio1.79x—————
Debt to equity0.09x—————
Return on equity5.5%†—————
Return on assets2.8%†—————
Return on capital employed6.7%†—————
Asset turnover1.43x†—————

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 -22 -2 26 3 -26
March 31, 2025 -14 3 11 0 -14

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 92 46 25 0 4 89 42 3 2 14
March 31, 2025 27 18 8 0 0 27 10 1 0 1

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.